This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 May 15;41(10):1536-7.

doi: 10.1016/0006-2952(91)90575-p.

Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice

H Safayhi¹, T Mack, H P Ammon

Affiliations

PMID: 2018558
DOI: 10.1016/0006-2952(91)90575-p

Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice

H Safayhi et al. Biochem Pharmacol. 1991.

. 1991 May 15;41(10):1536-7.

doi: 10.1016/0006-2952(91)90575-p.

Authors

H Safayhi¹, T Mack, H P Ammon

Affiliation

¹ Department of Pharmacology, University of Tübingen, Federal Republic of Germany.

PMID: 2018558
DOI: 10.1016/0006-2952(91)90575-p

No abstract available

PubMed Disclaimer

Similar articles

A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
Wendel A, Tiegs G. Wendel A, et al. Biochem Pharmacol. 1986 Jul 1;35(13):2115-8. doi: 10.1016/0006-2952(86)90578-2. Biochem Pharmacol. 1986. PMID: 3729968
Biochemical pharmacology of inflammatory liver injury in mice.
Wendel A. Wendel A. Methods Enzymol. 1990;186:675-80. doi: 10.1016/0076-6879(90)86166-s. Methods Enzymol. 1990. PMID: 2233326 No abstract available.
Suppressive effect of coffee on lipopolysaccharide-induced hepatitis in D-galactosamine-sensitized rats.
He P, Noda Y, Sugiyama K. He P, et al. Biosci Biotechnol Biochem. 2001 Aug;65(8):1924-7. doi: 10.1271/bbb.65.1924. Biosci Biotechnol Biochem. 2001. PMID: 11577746
Hepatoprotective effect of Curcuma longa L. in D-galactosamine induced liver injury in mice: evidence of antioxidant activity.
Adaramoye OA, Odunewu AO, Farombi EO. Adaramoye OA, et al. Afr J Med Med Sci. 2010 Dec;39 Suppl:27-34. Afr J Med Med Sci. 2010. PMID: 22416641
Mechanisms of hepatoprotection of Terminalia catappa L. extract on D-Galactosamine-induced liver damage.
Tang XH, Gao L, Gao J, Fan YM, Xu LZ, Zhao XN, Xu Q. Tang XH, et al. Am J Chin Med. 2004;32(4):509-19. doi: 10.1142/S0192415X04002156. Am J Chin Med. 2004. PMID: 15481641

See all similar articles

Cited by

Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.
Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK. Frank MB, et al. BMC Complement Altern Med. 2009 Mar 18;9:6. doi: 10.1186/1472-6882-9-6. BMC Complement Altern Med. 2009. PMID: 19296830 Free PMC article.
The journey of boswellic acids from synthesis to pharmacological activities.
Ragab EA, Abd El-Wahab MF, Doghish AS, Salama RM, Eissa N, Darwish SF. Ragab EA, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1477-1504. doi: 10.1007/s00210-023-02725-w. Epub 2023 Sep 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37740772 Free PMC article. Review.
Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells.
Liu JJ, Huang B, Hooi SC. Liu JJ, et al. Br J Pharmacol. 2006 Aug;148(8):1099-107. doi: 10.1038/sj.bjp.0706817. Epub 2006 Jun 19. Br J Pharmacol. 2006. PMID: 16783403 Free PMC article.
Effect of Boswellia serrata supplementation on blood lipid, hepatic enzymes and fructosamine levels in type2 diabetic patients.
Ahangarpour A, Heidari H, Fatemeh RA, Pakmehr M, Shahbazian H, Ahmadi I, Mombeini Z, Mehrangiz BH. Ahangarpour A, et al. J Diabetes Metab Disord. 2014 Feb 4;13(1):29. doi: 10.1186/2251-6581-13-29. J Diabetes Metab Disord. 2014. PMID: 24495344 Free PMC article.
Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.
Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HP, Safayhi H. Sailer ER, et al. Br J Pharmacol. 1996 Feb;117(4):615-8. doi: 10.1111/j.1476-5381.1996.tb15235.x. Br J Pharmacol. 1996. PMID: 8646405 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information